MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-50-0007505
Glary Pharmaceuticals Private Limited
Glary Pharmaceuticals Private Limited - pharma in Lucknow, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹41.39 Lakh
▲ 47% YoY
Net profit · FY 2024
₹25,212
Net margin 0.6%
EBITDA · FY 2024
₹1.47 Lakh
EBITDA margin 3.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹9 Lakh
Secured borrowings
Company age
19 yrs
Est. 2007
Directors on board
2
As per MCA filings
About Glary Pharmaceuticals Private Limited
Data last updated:
Glary Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 May 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24233UP2007PTC033337.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nilam Singh and Asha Singh.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 422 D Manas Enclave, Lucknow, Uttar Pradesh, India – 226015.
As per the financials filed for FY 2024, the company reported a revenue of ₹41.39 Lakh, a growth of 47% compared to the previous year. For the same year it recorded a net profit of ₹25,212 (net margin 0.6%) and EBITDA of ₹1.47 Lakh (EBITDA margin 3.5%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 12% over five years.
As per MCA filings, the company has open charges of ₹9 Lakh on record.
Glary Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0007505). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24233UP2007PTC033337
Registration Number 033337
Incorporation Date 22 May 2007
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-50-0007505
Key People
Nilam Singh Director Asha Singh Director Recognitions & Rankings of Glary Pharmaceuticals
Contact details
Glary Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address422 D Manas Enclave, Lucknow, Uttar Pradesh, India – 226015
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Glary Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Glary Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Glary Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Glary Pharmaceuticals Private Limited, buy the company report.
Financials of Glary Pharmaceuticals Private Limited
FY 2024 filings availableGlary Pharmaceuticals Private Limited reported revenue of ₹41.39 Lakh (up 47% YoY) for FY 2024.
Revenue · FY 2024
₹41.39 Lakh ▲ 47%
Net profit · FY 2024
₹25,212 margin 0.6%
EBITDA · FY 2024
₹1.47 Lakh margin 3.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 47%
3 years · compounded
▲ 9%
5 years · compounded
▲ 12%
EBITDA CAGR growth
1 year
▼ 5%
3 years · compounded
▲ 2%
5 years · compounded
▲ 19%
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 47% growth in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.47 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹25,212 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.5% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Glary Pharmaceuticals Private Limited, buy the company report.
Board of directors of Glary Pharmaceuticals Private Limited
Glary Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nilam Singh | Director | 08 Jun 2015 | 11 Years 4 Months | Current |
| Asha Singh | Director | 20 Apr 2019 | 7 Years 6 Months | Current |
Peer comparison
Glary Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mialtus Pharmaceuticals Private Limited | ₹41.44 Lakh (FY 2025) | 14.0% | Delhi, India | |||
| Genomics Healthcare Private Limited | ₹41.41 Lakh (FY 2020) | 30.0% | Howrah, West Bengal, India | |||
| Glary Pharmaceuticals Private Limitedthis company | ₹41.39 Lakh (FY 2024) | ₹25,212 | 0.6% | 47.0% | Lucknow, Uttar Pradesh, India | |
| Unimartpharma Private Limited | ₹41.33 Lakh (FY 2024) | Mumbai, Maharashtra, India | ||||
| Sarv Shakti Ayurvedic Pharmaceuticals Private Limited | ₹41.25 Lakh (FY 2016) | 13.0% | Amritsar, Punjab, India |
To see the full peer comparison of Glary Pharmaceuticals Private Limited, buy the company report.
Auditor
Glary Pharmaceuticals Private Limited is audited by R J C P SUBHASH MISRA & CO for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R J C P SUBHASH MISRA & CO | FY 2018 | 007415C |
Shareholding
The shareholding of Glary Pharmaceuticals Private Limited is on record for FY 2018, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2018 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Glary Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹9 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Jun 2014 | 10515868 | Allahabad Bank | ₹9 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Glary Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Glary Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Glary Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Glary Pharmaceuticals Private Limited has 5 board changes on record since 2015: 2 appointments and 3 cessations. The latest: Asha Singh was appointed as Director on 20 Apr 2019.
AGM
Glary Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Glary Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur.
Appointed
Asha Singh was appointed as Director.
Ceased
Rakesh Kumar Singh ceased to be Director.
Ceased
Nilam Singh ceased to be Additional Director.
Ceased
Munish Kumar Mishra ceased to be Director.
Appointed
Nilam Singh was appointed as Director.
Charges
A charge with Allahabad Bank amounted to Rs. 9.00 Lakh with Charge ID 10515868 was registered on 12 Jun 2014.
Incorporation
22 May 2007
Glary Pharmaceuticals Private Limited was registered on 22 May 2007 with Roc Kanpur & aged 19 years 5 months as per MCA records.
Frequently asked questions
Glary Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 May 2007 (19+ years old) and is registered under CIN U24233UP2007PTC033337.
Glary Pharmaceuticals has 2 current directors:
- Nilam Singh - Director
- Asha Singh - Director
The latest financial statements of Glary Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Glary Pharmaceuticals is U24233UP2007PTC033337. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Glary Pharmaceuticals was incorporated on 22 May 2007, making it 19+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Glary Pharmaceuticals by revenue are Mialtus Pharmaceuticals Private Limited, Genomics Healthcare Private Limited, Unimartpharma Private Limited, Sarv Shakti Ayurvedic Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Asha Singh was appointed as Director on 20 Apr 2019. Rakesh Kumar Singh ceased to be Director on 20 Apr 2019. Nilam Singh ceased to be Additional Director on 30 Sep 2015. Glary Pharmaceuticals has 5 board changes on record in total.
Yes, Glary Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-50-0007505).
The registered office of Glary Pharmaceuticals is at 422 D Manas Enclave, Lucknow, Uttar Pradesh, India – 226015.
Glary Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Glary Pharmaceuticals has open charges of ₹9 Lakh and no satisfied charges on record as per latest MCA filings.